Atlas Trials

Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells

Clinical trial NCT06277427 · RECRUITING

Trial details

NCT number
NCT06277427
Sponsor
Lingli Dong
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Lupus NephritisANCA Associated Vasculitis
Start date
2024-02-05
Primary completion
2026-02-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.